CULLINAN ONCOLOGY, INC.
One Main Street, Suite 1350
Cambridge, MA 02142
March 17, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Jimmy McNamara |
| Re: | Cullinan Oncology, Inc. |
Registration Statement on Form S-3 (File No. 333-270384)
Ladies and Gentlemen:
We hereby withdraw Cullinan Oncology Inc’s request for acceleration of effectiveness of the Registration Statement on Form S-3 (File No. 333-270384) made on March 9, 2023.
Please direct any questions regarding this filing to Tom Danielski at (617) 235-4961.
| CULLINAN ONCOLOGY, INC. | ||
| By: | /s/ Jeffrey Trigilio | |
| Name: |
Jeffrey Trigilio | |
| Title: |
Chief Financial Officer | |